Cargando…
NOP7 interacts with β-catenin and activates β-catenin/TCF signaling in hepatocellular carcinoma cells
BACKGROUND: The hyperactivation of β-catenin signaling is frequently observed in clinical hepatocellular carcinoma (HCC) samples. Further understanding the mechanisms involved in activating β-catenin/TCF signaling would benefit the treatment of HCC. METHOD AND RESULTS: Here, it was found that NOP7 w...
Autores principales: | Wu, Nan, Zhao, Jing, Yuan, Youhua, Lu, Chuanjia, Zhu, Wenjing, Jiang, Qun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6171516/ https://www.ncbi.nlm.nih.gov/pubmed/30319277 http://dx.doi.org/10.2147/OTT.S164601 |
Ejemplares similares
-
Nuclear Dvl, c-Jun, β-catenin, and TCF form a complex leading to stabiLization of β-catenin–TCF interaction
por: Gan, Xiao-qing, et al.
Publicado: (2008) -
Liver cancer: WISP3 suppresses hepatocellular carcinoma progression by negative regulation of β‐catenin/TCF/LEF signalling
por: Gao, Hong, et al.
Publicado: (2019) -
β-Catenin signaling in hepatocellular carcinoma
por: Xu, Chuanrui, et al.
Publicado: (2022) -
CARF activates beta-catenin/TCF signaling in the hepatocellular carcinoma
por: Fan, Xin, et al.
Publicado: (2016) -
NOP14 inhibits melanoma proliferation and metastasis by regulating Wnt/β-catenin signaling pathway
por: Li, Jingrong, et al.
Publicado: (2018)